Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea · Delayed Price · Currency is KRW 4,935.00
-5.00 (-0.10%)
Last updated: Sep 5, 2025, 12:02 PM KST
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 119.30 billion as of September 8, 2025. Its market cap has decreased by -35.53% in one year.
Market Cap
119.30B
Enterprise Value
226.79B
Revenue
236.54B
Ranking
n/a
PE Ratio
51.98
Stock Price
4,935.00
Market Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 119.30B, a decrease of -85.43%. That is a compound annual growth rate of -17.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 119.30B | -19.77% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | 390.88B | 97.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.38T |
| Celltrion | 37.45T |
| ALTEOGEN | 25.54T |
| Yuhan | 9,104.15B |
| SK Biopharmaceuticals | 8,575.30B |
| PharmaResearch | 7,013.01B |
| Peptron | 6,756.23B |
| LigaChem Biosciences | 5,523.68B |